All In MedTech

Device Trial Radar · NCT07156669

Safety and Performance of the Novalung Ultimate Kit and Xenios 2.0 During Stationary Use in Hospital and Ground-based Transport of Patients on Extracorporeal Life Support (ECLS)

Last checked: Nov 20, 2026Latest source record: Sep 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

May 19, 2026

Primary completion

Apr 2027

Study completion Jul 2027

Sponsor

Lead sponsor
Xenios AGNot on our public-company list
Sponsor type
Industry
Collaborators
Alcedis GmbH
First posted
Sep 5, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This prospective observational study will evaluate the safety and performance of the Novalung ultimate kit in combination with the Xenios 2.0 and the MultiSupport Ground during stationary use in hospital and ground-based transport of patients treated on extracorporeal membrane oxygenation (ECMO). The primary objective is to assess whether the use of the medical devices improves and maintains the gas exchange (blood oxygenation) in these patients. Medical Devices will be used according to their intended purpose and local standards/ requirements.

Conditions

  • Cardio-Respiratory Failure
  • Extracorporeal Membrane Oxygenation Complication
  • Acute Lung Injury

Interventions

  • Novalung ultimate kit, Xenios 2.0, and MultiSupport Ground (MSG)Device

    Patients will receive ECLS treatment using the Novalung ultimate kit, Xenios 2.0, and MultiSupport Ground (MSG) during ground-based inter-hospital patient transport and/ or stationary treatment according to their intended use and local standards/ requirements.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Arterial oxygen saturation (SaO2) [%]Time frame: Baseline and during the ECMO treatment every 24 hours until a maximum of 29 days

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • University Hospital Aachen

    Aachen, Germany · Recruiting

  • Krankenhaus Bethanien gGmbH

    Solingen, Germany · Recruiting

  • Helios Klinikum Erfurt

    Erfurt, Bavaria, Germany · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.